Werner Linkesch
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 15, 2020
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Journal: British journal of haematology
Published: August 03, 2016
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 12, 2015
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: May 26, 2014
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Journal: Annals of hematology
Published: April 08, 2014
R-CHOP versus R-COMP: are they really equally effective?
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 26, 2014
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
Journal: British journal of haematology
Published: January 19, 2014
Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Journal: Blood
Published: November 15, 2013
Last Updated: 09/26/2026